13287_2019_1349_MOESM1_ESM.png (315 kB)
Additional file 1: of NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions
figure
posted on 2019-09-24, 03:37 authored by Tithi Ghosh, Partha Nandi, Nilanjan Ganguly, Ipsita Guha, Avishek Bhuniya, Sarbari Ghosh, Anirban Sarkar, Akata Saha, Shayani Dasgupta, Rathindranath Baral, Anamika BoseFigure S1. Gating strategy of CD105+Vimentin+IL-10+ MSCs, as prescribed in Fig. 5b, are shown along with their respective FMO for both PBS and NLGP groups. (PNG 314 kb)
